Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Jon C. Ogg | Nov 21, 2011 at 7:51 AM EST

Gilead Paying Up (too much) for Pharmasset (GILD, VRUS)

Gilead Sciences Inc. (NASDAQ: GILD) is trading lower on news that it is spending some $11 billion to buy Pharmasset,…

David J. Phillips | Nov 17, 2011 at 1:45 PM EST

Dendreon Buyout, How Imminent?

Though near-term growth visibility for its cancer vaccine Provenge remains cloudy, Seattle-based Dendreon (DNDN) could be an attractive takeover candidate…

Douglas A. McIntyre | Nov 16, 2011 at 6:24 AM EST

America’s Psychiatric Drug Addition

“Sell crazy someplace else; we’re all stocked up here,” says Jack Nicholson in 1997’s As Good as It Gets. There…

Douglas A. McIntyre | Nov 10, 2011 at 6:28 AM EST

Walmart Denies Plans for Health Care Network, Even as Clinics Thrive

Walmart (NYSE: WMT) said that the press was mistaken when several media reported the world’s largest retailer would create a national…

Jon C. Ogg | Nov 7, 2011 at 10:04 AM EST

Vertex RA Study: When Good Is Not Good Enough (VRTX)

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) might have sounded as though shares would be up Monday morning if you were just…

Douglas A. McIntyre | Nov 5, 2011 at 11:07 AM EDT

The Eight Drug Shortages Putting Americans at Risk

President Obama this week signed an executive order directing federal regulators to address shortages of vital prescription drugs. According to…

Jon C. Ogg | Nov 3, 2011 at 10:59 AM EDT

Medivation, A Pain in the Rear for Dendreon (MDVN, DNDN)

Medivation, Inc. (NASDAQ: MDVN) is today’s darling in biotech and emerging pharmaceuticals. It and partner Astellas in Japan showed very…

Douglas A. McIntyre | Nov 2, 2011 at 6:19 AM EDT

Economics of Painkiller Abuse

The regions of the U.S. in which painkiller use is extremely high also tend to be the poorest sections of…

Jon C. Ogg | Oct 25, 2011 at 8:55 AM EDT

Healthways: The Implosion of the Day (HWAY, CI)

Healthways Inc. (NASDAQ: HWAY) could be named “The Implosion Stock of the Day.” Revenues rose 3.3% from a year earlier to…

Douglas A. McIntyre | Oct 25, 2011 at 6:24 AM EDT

Novartis Cuts 2,000 as Pharma Industry Continues to Falter

Novartis (NYSE: NVS) said it would cut 2,000 workers and outsource some functions to companies that will do the work…

Jon C. Ogg | Oct 24, 2011 at 10:24 AM EDT

Endless Mergers… More to Come! (CBST, ADLR, HS, CI, CVH, MAT, RNOW, ORCL, SLE, SJM, ANDS, NYX)

Monday is called “Merger Monday” for a reason and this morning is a classic example of its namesake. We have…

Paul Ausick | Oct 20, 2011 at 10:58 AM EDT

Lilly’s Drugs Closer to Edge of Patent Cliff (LLY, PFE, JNJ, BMY, SNY, MRK)

Drug maker Eli Lilly & Co. (NYSE: LLY) reported third-quarter earnings this morning, and the company did a little better…

Jon C. Ogg | Oct 19, 2011 at 11:34 AM EDT

Measuring Pre-Earnings Upside in Biotechs (DNDN, HGSI, GILD, AMLN, ARIA, INCY, IBB, XBI, BBH)

We have compiled a detailed list of expected upside in the biotech sector. The sector has consolidated and now there…

Jon C. Ogg | Oct 19, 2011 at 10:18 AM EDT

The Abbott Break-Up Seems To Make Sense (ABT, BIIB, BMY)

Drug and medical stocks are not generally thought of as stocks hitting 52-week highs by the investing public. So what…

Jon C. Ogg | Oct 12, 2011 at 2:10 PM EDT

Expected Upside Gains for Leading Pharmaceutical Companies (JNJ, PFE, AZN, BMY, MRK)

Sales for the big pharmaceutical companies are expected to be hit by pricing pressure in Europe, a lack of urgent…

1 … 324 325 326 327 328 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Gilead Paying Up (too much) for Pharmasset (GILD, VRUS)

Dendreon Buyout, How Imminent?

America’s Psychiatric Drug Addition

Walmart Denies Plans for Health Care Network, Even as Clinics Thrive

Vertex RA Study: When Good Is Not Good Enough (VRTX)

The Eight Drug Shortages Putting Americans at Risk

Medivation, A Pain in the Rear for Dendreon (MDVN, DNDN)

Economics of Painkiller Abuse

Healthways: The Implosion of the Day (HWAY, CI)

Novartis Cuts 2,000 as Pharma Industry Continues to Falter

Endless Mergers… More to Come! (CBST, ADLR, HS, CI, CVH, MAT, RNOW, ORCL, SLE, SJM, ANDS, NYX)

Lilly’s Drugs Closer to Edge of Patent Cliff (LLY, PFE, JNJ, BMY, SNY, MRK)

Measuring Pre-Earnings Upside in Biotechs (DNDN, HGSI, GILD, AMLN, ARIA, INCY, IBB, XBI, BBH)

The Abbott Break-Up Seems To Make Sense (ABT, BIIB, BMY)

Expected Upside Gains for Leading Pharmaceutical Companies (JNJ, PFE, AZN, BMY, MRK)

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

Brinker CEO Kevin Hochman: “We Are Firing on All Cylinders” After 20 Straight Quarters of Growth

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

Health and Healthcare Articles

All Health and Healthcare Articles

Gilead Paying Up (too much) for Pharmasset (GILD, VRUS)

Dendreon Buyout, How Imminent?

America’s Psychiatric Drug Addition

Walmart Denies Plans for Health Care Network, Even as Clinics Thrive

Vertex RA Study: When Good Is Not Good Enough (VRTX)

The Eight Drug Shortages Putting Americans at Risk

Medivation, A Pain in the Rear for Dendreon (MDVN, DNDN)

Economics of Painkiller Abuse

Healthways: The Implosion of the Day (HWAY, CI)

Novartis Cuts 2,000 as Pharma Industry Continues to Falter

Endless Mergers… More to Come! (CBST, ADLR, HS, CI, CVH, MAT, RNOW, ORCL, SLE, SJM, ANDS, NYX)

Lilly’s Drugs Closer to Edge of Patent Cliff (LLY, PFE, JNJ, BMY, SNY, MRK)

Measuring Pre-Earnings Upside in Biotechs (DNDN, HGSI, GILD, AMLN, ARIA, INCY, IBB, XBI, BBH)

The Abbott Break-Up Seems To Make Sense (ABT, BIIB, BMY)

Expected Upside Gains for Leading Pharmaceutical Companies (JNJ, PFE, AZN, BMY, MRK)

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

Brinker CEO Kevin Hochman: “We Are Firing on All Cylinders” After 20 Straight Quarters of Growth

Featured Reads

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up